Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$290K Sell
15,783
-59,052
-79% -$1.26M 0.03% 692
2026
Q1
$1.51M Sell
74,835
-23,622
-24% -$525K 0.11% 287
2025
Q4
$1.89M Buy
+98,457
New +$2.07M 0.15% 207
2024
Q3
Sell
-20,029
Closed -$495K 461
2024
Q2
$495K Buy
20,029
+7,310
+57% +$208K 0.05% 333
2024
Q1
$419K Buy
+12,719
New +$433K 0.05% 364

Other funds holding ADNT

Atom Investors's ADNT Position: Q2 2026 in Review

Atom Investors reduced its Adient (ADNT) stake by 79% in Q2 2026, selling an estimated $1.26M and leaving 15,783 shares worth $290K. The position accounts for 0.03% of the portfolio, ranked #692.

Atom Investors first reported a position in ADNT in Q1 2024 and has held it in 5 quarters since. The position peaked at $1.89M in Q4 2025. 313 funds tracked by Wall St. Rank hold ADNT as of Q2 2026.

  • Atom Investors held 15,783 shares of Adient worth $290K as of Q2 2026.
  • Atom Investors sold 59,052 Adient shares in Q2 2026, an estimated $1.26M.
  • Adient made up 0.03% of Atom Investors's portfolio in Q2 2026, its #692 holding.
  • Atom Investors first reported a position in Adient in Q1 2024 and has held it in 5 quarters since.
  • Atom Investors's Adient position peaked at $1.89M in Q4 2025.
  • 313 funds tracked by Wall St. Rank held Adient as of Q2 2026.

Based on Atom Investors's 13F filing for Q2 2026, filed 14 Aug 2026.